Lanqing Intelligence

Lanqing Intelligence develops industrial AI software for the manufacturing floor. Its core product is a computer-vision inspection system that uses high-precision imaging and recognition algorithms to identify surface defects, assembly errors and dimensional deviation on the line in real time. It has extended this into a process optimization module that suggests parameter adjustments from line data.

Customers are concentrated in electronics manufacturing — contract manufacturers and precision component producers. Revenue comes from software licensing, charged per line or workstation, and deployment services handled by an engineering team. Deployment revenue runs roughly comparable to software revenue, a mix that sets it apart from a pure software vendor.

Over the past two years, Lanqing has begun extending into materials and pharmaceutical production lines. Inspection needs there differ structurally from electronics — materials manufacturers prioritize batch consistency, pharmaceutical lines face stricter compliance requirements — and it has built dedicated delivery teams for each rather than adapting its electronics configuration wholesale.

The initial investment in Lanqing Intelligence was made in 2020 under the technology investments strategy, when the company had already established a repeatable deployment methodology in electronics, with verifiable records on accuracy and delivery timelines. The strategy's emphasis on dedicated study of business model and competitive dynamics shaped the question: not any single algorithmic breakthrough, but whether the model could replicate across industries.

Extending into materials and pharmaceuticals was judged decisive to long-term value: dependence on electronics alone carries exposure to cyclical demand swings, while the algorithms carry cross-industry transferability. The thesis centered on organizational capability — whether the company could build independent delivery capacity in new industries while holding electronics to the same discipline.

Manufacturing quality inspection has long relied on manual checks, a model under sustained pressure as labor costs rise and skilled inspectors grow scarce, while computer vision has matured enough to meet real-time, full-coverage needs in a meaningful share of cases, giving deployment-capable software companies a continuing source of work.

Inspection demand in materials and pharmaceutical lines has developed later, and purchasing decisions tend to be more cautious, with compliance requirements raising the bar for new entrants. This creates room for a company with a proven methodology, though expansion will be governed by customers' internal compliance processes and pilot cycles.

Havrion Capital holds a minority position in Lanqing Intelligence and participates at board level in discussions on the pace of industry expansion, in particular whether investment intensity in materials and pharmaceuticals is proportionate to the company's cash position.

On organizational support, the focus has been standardizing recruitment and project management so delivery quality holds steady while the company serves three distinct industry customer bases at once. Further capital will be committed in stages as the newer businesses prove themselves.